Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Movement Disorders : Official Journal of the Movement Disorder Society|November 1, 1996
Subacute encephalomyelitis presenting as stiff-person syndrome: clinical, polygraphic, and pathologic correlationsC Armon, J W Swanson, J M McLean, et al.
Neurology|November 4, 2000
Rapid-onset dystonia-parkinsonism: a clinical and genetic analysis of a new kindredS J Pittock, C Joyce, V O'Keane, et al.
Journal of the Neurological Sciences|January 7, 1998
A brief quality-of-life measure for ALS clinical trials based on a subset of items from the sickness impact profile. The Syntex-Synergen ALS/CNTF Study GroupD McGuire, L Garrison, C Armon, et al.
Revue Neurologique|April 2, 2026
Neuroimaging confirms selective cerebral involvement in primary lateral sclerosis and predilection to brain regions with high metabolic activityJ Kleinerova, M Tahedl, E Finegan, et al.
Neurology|April 1, 1998
Toward earlier diagnosis of amyotrophic lateral sclerosis: revised criteria. rhCNTF ALS Study GroupM A Ross, R G Miller, L Berchert, et al.
The Journal of Antimicrobial Chemotherapy|June 23, 2016
CD4 cell count at initiation of ART, long-term likelihood of achieving CD4 >750 cells/mm3 and mortality riskF J Palella, C Armon, J S Chmiel, et al.
Neurology|June 30, 2006
ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B)N Parkinson, P G Ince, M O Smith, et al.
Muscle & Nerve|June 1, 1997
Reliability of maximal voluntary isometric contraction testing in a multicenter study of patients with amyotrophic lateral sclerosis. Syntex/Synergen Neuroscience Joint Venture rhCNTF ALS Study GroupR J Hoagland, M Mendoza, C Armon, et al.
Annals of Neurology|February 1, 1996
A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. rhCNTF ALS Study GroupR G Miller, J H Petajan, W W Bryan, et al.
Neurology|February 22, 2012
Evidence-based guideline update: intraoperative spinal monitoring with somatosensory and transcranial electrical motor evoked potentials: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the American Clinical Neurophysiology SocietyM R Nuwer, R G Emerson, G Galloway, et al.
Pageof 9